Fibrostenotic Crohn´s Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Fibrostenotic Crohn´s Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Fibrostenotic Crohn´s Disease trials you may qualify forThis is a Phase 1b, open-label, exploratory study designed to evaluate the pharmacodynamic effects of PALI-2108, a phosphodiesterase-4 (PDE4) inhibitor, in pati…
Many patients with Crohn's disease develop fibrotic narrowing (strictures) in their bowel, causing obstructive symptoms such as abdominal pain, cramping, or vom…